To investigate the association between PVR expression, serum amylase, IGFBP-7, and TIMP-2 with the survival outcomes of multiple myeloma (MM) patients, we analyzed the overall survival (OS) and progression-free survival (PFS) in relation to PVR expression status (Tables 4, 5). The gene discussed is IGFBP7; the disease is plasma cell myeloma.